# Rhenman & Partners Asset Management AB

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1599882. Source: https://holderbook.com/funds/1599882-rhenman-partners-asset-management-ab/

- Reported value: $1.1B
- Positions: 99
- Weight of the ten largest: 25.1%
- Filed: 2026-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $38.9M | 93,600 | 3.7% | 31 |
| CVS HEALTH CORP | [CVS](https://holderbook.com/stocks/CVS/) | $28.9M | 279,374 | 2.7% | 8 |
| ASTRAZENECA PLC | [AZN](https://holderbook.com/stocks/AZN/) | $28.5M | 151,500 | 2.7% | 1 |
| MERCK & CO INC | [MRK](https://holderbook.com/stocks/MRK/) | $27.4M | 213,500 | 2.6% | 1 |
| ELI LILLY & CO | [LLY](https://holderbook.com/stocks/LLY/) | $26.8M | 22,315 | 2.5% | 13 |
| ABBVIE INC | [ABBV](https://holderbook.com/stocks/ABBV/) | $24.4M | 96,775 | 2.3% | 28 |
| ALIGNMENT HEALTHCARE INC | [ALHC](https://holderbook.com/stocks/ALHC/) | $23.7M | 997,083 | 2.2% | 16 |
| EDWARDS LIFESCIENCES CORP | [EW](https://holderbook.com/stocks/EW/) | $23.5M | 260,000 | 2.2% | 5 |
| GILEAD SCIENCES INC | [GILD](https://holderbook.com/stocks/GILD/) | $22.5M | 178,250 | 2.1% | 25 |
| JAZZ PHARMACEUTICALS PLC | [JAZZ](https://holderbook.com/stocks/JAZZ/) | $21.1M | 87,440 | 2.0% | 31 |
| BIOGEN INC | [BIIB](https://holderbook.com/stocks/BIIB/) | $20.5M | 94,850 | 1.9% | 16 |
| STRYKER CORPORATION | [SYK](https://holderbook.com/stocks/SYK/) | $20.5M | 65,000 | 1.9% | 2 |
| BOSTON SCIENTIFIC CORP | [BSX](https://holderbook.com/stocks/BSX/) | $19.2M | 450,500 | 1.8% | 31 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $18.4M | 72,500 | 1.7% | 1 |
| GUARDANT HEALTH INC | [GH](https://holderbook.com/stocks/GH/) | $17.3M | 115,000 | 1.6% | 4 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $17.1M | 27,390 | 1.6% | 18 |
| GLAUKOS CORP | [GKOS](https://holderbook.com/stocks/GKOS/) | $16.6M | 119,000 | 1.6% | 31 |
| BIOMARIN PHARMACEUTICAL INC | [BMRN](https://holderbook.com/stocks/BMRN/) | $16.6M | 290,500 | 1.6% | 31 |
| NURIX THERAPEUTICS INC | [NRIX](https://holderbook.com/stocks/NRIX/) | $16.6M | 684,250 | 1.6% | 9 |
| NATERA INC | [NTRA](https://holderbook.com/stocks/NTRA/) | $16.6M | 61,050 | 1.6% | 16 |
| MIRUM PHARMACEUTICALS INC | [MIRM](https://holderbook.com/stocks/MIRM/) | $16.3M | 139,205 | 1.5% | 10 |
| INSMED INC | [INSM](https://holderbook.com/stocks/INSM/) | $16.2M | 151,960 | 1.5% | 9 |
| TENET HEALTHCARE CORP | [THC](https://holderbook.com/stocks/THC/) | $15.9M | 85,200 | 1.5% | 21 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $15.8M | 31,580 | 1.5% | 26 |
| CENTENE CORP DEL | [CNC](https://holderbook.com/stocks/CNC/) | $15.7M | 244,000 | 1.5% | 1 |
| AXSOME THERAPEUTICS INC | [AXSM](https://holderbook.com/stocks/AXSM/) | $15.4M | 63,050 | 1.5% | 14 |
| DANAHER CORP DEL | [DHR](https://holderbook.com/stocks/DHR/) | $15.3M | 80,252 | 1.4% | 19 |
| VERTEX PHARMACEUTICALS INC | [VRTX](https://holderbook.com/stocks/VRTX/) | $15.2M | 30,685 | 1.4% | 31 |
| ANTERIS TECHNOLOGIES GLOBAL | [AVR](https://holderbook.com/stocks/AVR/) | $15.2M | 1,538,625 | 1.4% | 6 |
| NEUROCRINE BIOSCIENCES INC | [NBIX](https://holderbook.com/stocks/NBIX/) | $14.5M | 85,841 | 1.4% | 31 |
| PENNANT GROUP INC | [PNTG](https://holderbook.com/stocks/PNTG/) | $13.7M | 371,471 | 1.3% | 3 |
| INTUITIVE SURGICAL INC | [ISRG](https://holderbook.com/stocks/ISRG/) | $13.7M | 34,500 | 1.3% | 27 |
| ELEVANCE HEALTH INC FORMERLY | [ELV](https://holderbook.com/stocks/ELV/) | $13.5M | 34,900 | 1.3% | 31 |
| LIVANOVA PLC | [LIVN](https://holderbook.com/stocks/LIVN/) | $13.5M | 164,000 | 1.3% | 5 |
| CENCORA INC | [COR](https://holderbook.com/stocks/COR/) | $13.2M | 46,778 | 1.2% | 22 |
| CHARLES RIV LABS INTL INC | [CRL](https://holderbook.com/stocks/CRL/) | $13.0M | 57,200 | 1.2% | 3 |
| IDEAYA BIOSCIENCES INC | [IDYA](https://holderbook.com/stocks/IDYA/) | $12.8M | 343,800 | 1.2% | 3 |
| MCKESSON CORP | [MCK](https://holderbook.com/stocks/MCK/) | $12.5M | 16,550 | 1.2% | 22 |
| SYNDAX PHARMACEUTICALS INC | [SNDX](https://holderbook.com/stocks/SNDX/) | $12.2M | 560,250 | 1.2% | 10 |
| BRIGHTSPRING HEALTH SVCS INC | [BTSG](https://holderbook.com/stocks/BTSG/) | $11.6M | 165,896 | 1.1% | 4 |
| MEDTRONIC PLC | [MDT](https://holderbook.com/stocks/MDT/) | $11.3M | 145,000 | 1.1% | 31 |
| MINERALYS THERAPEUTICS INC | [MLYS](https://holderbook.com/stocks/MLYS/) | $11.2M | 416,371 | 1.1% | 4 |
| OSCAR HEALTH INC | [OSCR](https://holderbook.com/stocks/OSCR/) | $11.2M | 392,000 | 1.1% | 3 |
| ROYALTY PHARMA PLC | [RPRX](https://holderbook.com/stocks/RPRX/) | $11.0M | 197,000 | 1.0% | 17 |
| DEXCOM INC | [DXCM](https://holderbook.com/stocks/DXCM/) | $10.8M | 160,000 | 1.0% | 1 |
| ALIGN TECHNOLOGY INC | [ALGN](https://holderbook.com/stocks/ALGN/) | $10.6M | 63,000 | 1.0% | 11 |
| SPYRE THERAPEUTICS INC | [SYRE](https://holderbook.com/stocks/SYRE/) | $10.6M | 119,300 | 1.0% | 1 |
| RELAY THERAPEUTICS INC | [RLAY](https://holderbook.com/stocks/RLAY/) | $10.6M | 566,000 | 1.0% | 15 |
| ARROWHEAD PHARMACEUTICALS IN | [ARWR](https://holderbook.com/stocks/ARWR/) | $10.4M | 128,000 | 1.0% | 3 |
| AGILENT TECHNOLOGIES INC | [A](https://holderbook.com/stocks/A/) | $10.0M | 75,000 | 0.9% | 3 |
| NEKTAR THERAPEUTICS | [NKTR](https://holderbook.com/stocks/NKTR/) | $9.9M | 141,250 | 0.9% | 2 |
| ALKERMES PLC | [ALKS](https://holderbook.com/stocks/ALKS/) | $9.7M | 185,250 | 0.9% | 31 |
| ABBOTT LABORATORIES | [ABT](https://holderbook.com/stocks/ABT/) | $8.7M | 96,000 | 0.8% | 2 |
| DIANTHUS THERAPEUTICS INC | [DNTH](https://holderbook.com/stocks/DNTH/) | $8.4M | 86,127 | 0.8% | 8 |
| PROCEPT BIOROBOTICS CORP | [PRCT](https://holderbook.com/stocks/PRCT/) | $7.8M | 345,000 | 0.7% | 13 |
| STRUCTURE THERAPEUTICS INC | [GPCR](https://holderbook.com/stocks/GPCR/) | $7.8M | 145,100 | 0.7% | 6 |
| ORUKA THERAPEUTICS INC | [ORKA](https://holderbook.com/stocks/ORKA/) | $7.6M | 80,000 | 0.7% | 1 |
| ENCOMPASS HEALTH CORP | [EHC](https://holderbook.com/stocks/EHC/) | $7.5M | 74,263 | 0.7% | 10 |
| MOONLAKE IMMUNOTHERAPEUTICS | [MLTX](https://holderbook.com/stocks/MLTX/) | $7.5M | 384,800 | 0.7% | 6 |
| IOVANCE BIOTHERAPEUTICS INC | [IOVA](https://holderbook.com/stocks/IOVA/) | $7.1M | 1,705,327 | 0.7% | 31 |
| BRIDGEBIO PHARMA INC | [BBIO](https://holderbook.com/stocks/BBIO/) | $6.8M | 91,100 | 0.6% | 3 |
| KURA ONCOLOGY INC | [KURA](https://holderbook.com/stocks/KURA/) | $6.5M | 591,500 | 0.6% | 10 |
| INSULET CORP | [PODD](https://holderbook.com/stocks/PODD/) | $6.4M | 42,000 | 0.6% | 11 |
| ERASCA INC | [ERAS](https://holderbook.com/stocks/ERAS/) | $6.4M | 349,000 | 0.6% | 1 |
| KRYSTAL BIOTECH INC | [KRYS](https://holderbook.com/stocks/KRYS/) | $6.1M | 16,325 | 0.6% | 10 |
| STEVANATO GROUP S P A | [STVN](https://holderbook.com/stocks/STVN/) | $5.5M | 305,972 | 0.5% | 4 |
| ASTRANA HEALTH INC | [ASTH](https://holderbook.com/stocks/ASTH/) | $5.5M | 118,888 | 0.5% | 1 |
| CARDINAL HEALTH INC | [CAH](https://holderbook.com/stocks/CAH/) | $5.3M | 22,500 | 0.5% | 2 |
| ALNYLAM PHARMACEUTICALS INC | [ALNY](https://holderbook.com/stocks/ALNY/) | $5.2M | 17,200 | 0.5% | 31 |
| MOLINA HEALTHCARE INC | [MOH](https://holderbook.com/stocks/MOH/) | $5.0M | 21,857 | 0.5% | 1 |
| VIKING THERAPEUTICS INC | [VKTX](https://holderbook.com/stocks/VKTX/) | $5.0M | 128,000 | 0.5% | 14 |
| THE CIGNA GROUP | [CI](https://holderbook.com/stocks/CI/) | $4.8M | 17,400 | 0.5% | 31 |
| IONIS PHARMACEUTICALS INC | [IONS](https://holderbook.com/stocks/IONS/) | $4.7M | 59,900 | 0.4% | 9 |
| AMN HEALTHCARE SVCS INC | [AMN](https://holderbook.com/stocks/AMN/) | $4.7M | 144,466 | 0.4% | 1 |
| DENALI THERAPEUTICS INC | [DNLI](https://holderbook.com/stocks/DNLI/) | $4.6M | 179,000 | 0.4% | 6 |
| MEDPACE HLDGS INC | [MEDP](https://holderbook.com/stocks/MEDP/) | $4.5M | 8,500 | 0.4% | 1 |
| MADRIGAL PHARMACEUTICALS INC | [MDGL](https://holderbook.com/stocks/MDGL/) | $4.3M | 8,050 | 0.4% | 4 |
| AMGEN INC | [AMGN](https://holderbook.com/stocks/AMGN/) | $4.3M | 11,900 | 0.4% | 3 |
| SIONNA THERAPEUTICS INC | [SION](https://holderbook.com/stocks/SION/) | $4.3M | 97,100 | 0.4% | 2 |
| ASCENDIS PHARMA A/S | [ASND](https://holderbook.com/stocks/ASND/) | $4.0M | 15,000 | 0.4% | 1 |
| COOPER COS INC | [COO](https://holderbook.com/stocks/COO/) | $3.9M | 54,000 | 0.4% | 10 |
| WAYSTAR HLDG CORP | [WAY](https://holderbook.com/stocks/WAY/) | $3.7M | 178,566 | 0.3% | 2 |
| MBX BIOSCIENCES INC | [MBX](https://holderbook.com/stocks/MBX/) | $3.4M | 62,000 | 0.3% | 1 |
| VERICEL CORP | [VCEL](https://holderbook.com/stocks/VCEL/) | $3.1M | 70,000 | 0.3% | 5 |
| VEEVA SYS INC | [VEEV](https://holderbook.com/stocks/VEEV/) | $3.1M | 17,300 | 0.3% | 2 |
| BICARA THERAPEUTICS INC | [BCAX](https://holderbook.com/stocks/BCAX/) | $2.6M | 88,150 | 0.2% | 1 |
| STERIS PLC | [STE](https://holderbook.com/stocks/STE/) | $2.4M | 11,500 | 0.2% | 3 |
| OCULAR THERAPEUTIX INC | [OCUL](https://holderbook.com/stocks/OCUL/) | $2.2M | 225,000 | 0.2% | 4 |
| STOKE THERAPEUTICS INC | [STOK](https://holderbook.com/stocks/STOK/) | $2.1M | 64,500 | 0.2% | 4 |
| XENON PHARMACEUTICALS INC | [XENE](https://holderbook.com/stocks/XENE/) | $2.0M | 33,250 | 0.2% | 9 |
| DOXIMITY INC | [DOCS](https://holderbook.com/stocks/DOCS/) | $1.6M | 76,107 | 0.1% | 5 |
| PRIVIA HEALTH GROUP INC | [PRVA](https://holderbook.com/stocks/PRVA/) | $1.3M | 50,000 | 0.1% | 1 |
| NOVOCURE LTD | [NVCR](https://holderbook.com/stocks/NVCR/) | $1.1M | 70,000 | 0.1% | 2 |
| MINIMED GROUP INC | [MMED](https://holderbook.com/stocks/MMED/) | $822.2K | 55,000 | 0.1% | 1 |
| ALPHATEC HLDGS INC | [ATEC](https://holderbook.com/stocks/ATEC/) | $735.2K | 85,000 | 0.1% | 4 |
| AGILON HEALTH INC | [AGL](https://holderbook.com/stocks/AGL/) | $535.9K | 5,000 | 0.1% | 1 |
| 10X GENOMICS INC | [TXG](https://holderbook.com/stocks/TXG/) | $325.9K | 8,500 | 0.0% | 1 |
| TANDEM DIABETES CARE INC | [TNDM](https://holderbook.com/stocks/TNDM/) | $301.8K | 20,000 | 0.0% | 1 |
| TG THERAPEUTICS INC | [TGTX](https://holderbook.com/stocks/TGTX/) | $274.7K | 5,000 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +11.9% | +14.8% | -2.9% | 100% |
| Q1 2026 | -6.5% | -4.6% | -1.9% | 100% |
| Q4 2025 | +16.0% | +2.4% | +13.7% | 99% |
| Q3 2025 | +3.3% | +7.8% | -4.5% | 100% |
| Q2 2025 | -1.6% | +10.5% | -12.1% | 100% |
| Q1 2025 | +1.0% | -4.6% | +5.5% | 100% |
| Q4 2024 | -10.3% | +2.1% | -12.5% | 100% |
| Q3 2024 | +8.2% | +5.4% | +2.7% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.1B | 99 |
| Q1 2026 | $810.5M | 86 |
| Q4 2025 | $1.1B | 94 |
| Q3 2025 | $903.7M | 92 |
| Q2 2025 | $791.0M | 90 |
| Q1 2025 | $870.0M | 94 |
| Q4 2024 | $972.9M | 92 |
| Q3 2024 | $1.2B | 95 |
| Q2 2024 | $1.0B | 93 |
| Q1 2024 | $1.1B | 84 |
| Q4 2023 | $1.0B | 85 |
| Q3 2023 | $927.5M | 85 |